Literature DB >> 12702730

Bcl-2 protein is required for the adenine/uridine-rich element (ARE)-dependent degradation of its own messenger.

Annamaria Bevilacqua1, Maria Cristina Ceriani, Gianfranco Canti, Laura Asnaghi, Roberto Gherzi, Gary Brewer, Laura Papucci, Nicola Schiavone, Sergio Capaccioli, Angelo Nicolin.   

Abstract

We have shown previously that the decay of human bcl-2 mRNA is mediated by an adenine/uridine-rich element (ARE) located in the 3'-untranslated region. Here, we have utilized a non-radioactive cell-free mRNA decay system to investigate the biochemical and functional mechanisms regulating the ARE-dependent degradation of bcl-2 mRNA. Using RNA substrates, mutants, and competitors, we found that decay is specific and ARE-dependent, although maximized by the ARE-flanking regions. In unfractionated extracts from different cell types and in whole cells, the relative enzymatic activity was related to the amount of Bcl-2 protein expressed by the cells at steady state. The degradation activity was lost upon Bcl-2 depletion and was reconstituted by adding recombinant Bcl-2. Ineffective extracts from cells that constitutively do not express Bcl-2 acquire full degradation activity by adding recombinant Bcl-2 protein. We conclude that Bcl-2 is necessary to activate the degradation complex on the relevant RNA target.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12702730     DOI: 10.1074/jbc.M210620200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  B cell lymphoma (Bcl)-2 protein is the major determinant in bcl-2 adenine-uridine-rich element turnover overcoming HuR activity.

Authors:  Laura Ghisolfi; Angela Calastretti; Sara Franzi; Gianfranco Canti; Martino Donnini; Sergio Capaccioli; Angelo Nicolin; Annamaria Bevilacqua
Journal:  J Biol Chem       Date:  2009-06-11       Impact factor: 5.157

2.  zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia.

Authors:  Andrea Lapucci; Matteo Lulli; Amedeo Amedei; Laura Papucci; Ewa Witort; Federico Di Gesualdo; Francesco Bertolini; Gary Brewer; Angelo Nicolin; Annamaria Bevilacqua; Nicola Schiavone; Dominique Morello; Martino Donnini; Sergio Capaccioli
Journal:  FASEB J       Date:  2010-01-26       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.